"We have to seek out risks in order to improve prevention."

Around 300 specialists met on 22 and 23 November 2017 at the Swiss Public Health Conference in Basel to examine personalised health from scientific, ethical and economic perspectives. They discussed the opportunities and risks presented by personalised medicine, finding a balance between protection of and access to personal data, research in the age of precision medicine, the significance of prevention when it comes to improving health and people's quality of life, as well as public health in a global context. "We can measure thousands of molecules in a person's body fluids and tissue. We can map a person's lifestyle or gain information about their social networks." These were the opening remarks of epidemiologist and public-health specialist Nicole Probst-Hensch from the Swiss Tropical and Public Health Institute (Swiss TPH) at the start of the Swiss Public Health Conference 2017 in Basel. On 22 and 23 November 2017, around 300 specialists from the fields of science, politics, NGOs and the private sector convened at the Congress Center Basel to discuss the topic of "Personalised Health from a Public-Health Perspective". The conference was organised by Public Health Schweiz, the Swiss School of Public Health and Swiss TPH. Opportunities and Risks Presented by Personalised Health The amount of data and number of sources continue to grow, as do the opportunities to connect this information in order to better measure and understand the current state of our health.